Subclinical impairment of left ventricular function in young obese women: Contributions of polycystic ovary disease and insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 10, 2008, Pages 3748-3754

  Kosmala, Wojciech ^a   O'Moore Sullivan, Trisha M ^b   Plaksej, Rafal ^a   Kuliczkowska Plaksej, Justyna ^a   Przewlocka Kosmala, Monika ^a   Marwick, Thomas H ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANDROGEN; INSULIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 53749085842     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1017     Document Type: Article

References (36)

1. Kenchaiah S, Evans JC, Levy D Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS 2002 Obesity and the risk of heart failure. N Engl J Med 347:305-313
2. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ 2004 Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109:2191-2196
3. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH 2004 Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 110:3081-3087
4. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Di Mario U, Leonetti F 2004 Adapted changes in left ventricular structure and function in severe uncomplicated obesity. Obes Res 12:1616-1621
5. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L 2005 Insulin resistance and risk of congestive heart failure. JAMA 294:334-341
6. Di Bello V, Santini F, Di Cori A, Pucci A, Palagi C, Delle Donne MG, Fierabracci P, Marsili A, Talini E, Giannetti M, Biadi O, Balbarini A, Mariani M, Pinchera A 2006 Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study. J Am Soc Echocardiogr 19:1063-1071
7. Wild S, Pirpoint T, McKeigue P, Jacobs H 2000 Cardiovascular disease in womenwith polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600
8. Orio F, Palomba S, Spinelli L, Cacsella T, Tauchmanova L, Zullo F, Lombardi G, Colao A 2004 The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 89:3696-3701
9. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS 2004 Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:5454-5461
10. Marwick TH 2006 Measurement of strain and strain rate by echocardiography. Ready for prime time? J Am Coll Cardiol 47:1313-1327
11. American Diabetes Association 2008 Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55-S60
12. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
13. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M 1998 Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643-1649
14. Altuntas Y, Bilir M, Ozturk B, Gundogdu S 2003 Comparison of various simple insulin sensitivity and β-cell function indices in lean hyperandrogenemic and normoandrogenemic young hirsute women. Fertil Steril 80:133-142
15. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torrens JI, SWAN Investigators 2005 Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111:1242-1249
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463
17. De Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH 1994 Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23:600-606
18. Vasan RS 2003 Cardiac function and obesity. Heart 89:1127-1129
19. Lee KW, Lip GY 2003 Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE? J Hum Hypertens 17:299-304
20. Di Bello V, Santini F, Di Cori A, Pucci A, Palagi C, Delle Donne MG, Giannetti M, Talini E, Nardi C, Pedrizzetti G, Fierabracci P, Vitti P, Pinchera A, Balbarini A 2006 Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging Study. Int J Obes (Lond) 30:948-956
21. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H 1999 Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens 17:1153-1160
22. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F 2002 Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 10:767-773
23. Olsen MH, Hjerkinn E, Wachtell K, Hoieggen A, Bella JN, Nesbitt SD, Fossum E, Kjeldsen SE, Julius S, Ibsen H 2003 Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens 17:305-311
24. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson PW, Vasan RS 2003 Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107:448-454
25. Brantsma AH, Bakker SJ, Hillege HL, De Zeeuw D, De Jong PE, Gansevoort RT, PREVEND Study Group 2005 Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28:2525-2530
26. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM 1998 Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47:793-800
27. Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC 1992 Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 42:1160-1168
28. McFarlane SI, Banerji M, Sowers JR 2001 Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86:713-718
29. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL 2003 The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 88:1528-1533
30. Loukovaara M, Carson M, Adlercreutz H 1995 Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Clin Endocrinol Metab 80:160-164
31. Pugeat M, Moulin P, Cousin P, Fimbel S, Nicolas MH, Crave JC, Lejeuene H 1995 Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk. J Steroid Biochem Mol Biol 53:567-572
32. Kahn SM, Hryb DJ, Nakhla AM, Romas NA, Rosner W 2002 Sex hormone-binding globulin is synthesized in target cells. J Endocrinol 175:113-120
33. Tekin A, Tekin G, Colkesen Y, Kilicdag E, Bashan I, Sezgin AT, Muderrisoglu H 2008 Left ventricular function in patients with polycystic ovary syndrome: a tissue Doppler echocardiographic study. Eur J Clin Invest 38:350-351
34. Tíras MB, Yalcìn R, Noyan V, Maral I, Yìldìrìm M, Dörtlemez O, Daya S 1999 Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 14:1949-1952
35. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP 2003 Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284:H1560-H1569
36. Scheuer J, Malhotra A, Schaible TF, Capasso J 1987 Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61:12-19